Search filters

List of works by Pascaline Boudou-Rouquette

Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib

scientific article published on 22 August 2008

Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival

scientific article published on 13 March 2013

Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient.

scientific article published on 24 July 2009

Cancer in Africa, a new health challenge. Examples of Mali and OncoMali

scientific article published in August 2010

Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy

scientific article

Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTI

scientific article published on 22 October 2021

Development and validation of an ELISA method for the quantification of nivolumab in plasma from non-small-cell lung cancer patients

scientific article published on 24 February 2017

Drug interactions with solid tumour-targeted therapies

scientific article

Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma

scientific article

Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study

scientific article

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers

scientific article

Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old

scientific article published on 29 October 2016

Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

scientific article published in August 2017

Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2.

scientific article

Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis

scientific article

Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS).

scientific article

Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib

scientific article

Impaired Tumor-infiltrating T Cells in Patients with COPD Impacts Lung Cancer Response to PD-1 Blockade

scientific article published on 8 March 2018

Imprint cytology in tumor tissue bank quality control: an efficient method to evaluate tumor necrosis and to detect samples without tumor cells

scientific article

Individualized Pazopanib Dosing-Letter

scientific article published in October 2017

Integration of Oncology and Palliative Care, a Forgotten Indicator: Shared Decision-Making

scientific article published on 7 August 2015

Metastatic fractures of long limb bones

scientific article published on 11 January 2017

Nutritional status is superior to the ECOG performance status in predicting the dose-intensity of the GEMOX chemotherapy regimen in patients with advanced cancer

scientific article published on 7 October 2013

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

scientific article

Potential drug-drug interactions with abiraterone in metastatic castration-resistant prostate cancer patients: a prevalence study in France

scientific article published on 30 March 2017

Prognostic and predictive factors in epithelial ovarian cancer

scientific article

Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy

scientific article published on 29 March 2017

Resting energy expenditure in the risk assessment of anticancer treatments

scientific article

Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients

scientific article

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

scientific article published on 5 March 2013

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

scientific article (publication date: 2012)

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients

scientific article

Soluble VEGFR-1: a new biomarker of sorafenib-related hypertension (i.e., sorafenib-related is the compound adjective?).

scientific article published on 30 December 2014

Sorafenib for patients with differentiated thyroid cancer.

scientific article published in January 2015

Sorafenib in thyroid cancer patients: learning from toxicity

scientific article published on 22 July 2014

Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis

scientific article